Endobetix For Profit

Endobetix is developing a nonsurgical implant for the treatment of type 2 diabetes. The implant mimics the hormonal benefits offered by bariatric surgery. Implanted endoscopically, the device diverts bile and pancreatic secretions from the duodenum to the jejunum.

Headquarters: 17 Tchelet Street, Misgav
Technology: TeleHealth
Industry: AgeTech